The results from a new study of the multi-kinase inhibitor fexagratinib in mouse models are raising hopes that the therapy ...
Evening Standard on MSN3d
What is lupus? New treatment could end the need for lifelong medicationThree patients have undergone CAR T-cell therapy, which genetically alters their immune system to protect their organs ...
Get Surrey on MSN5d
The early signs and symptoms of Multiple Sclerosis to watch for - from fatigue to vision problemsMultiple sclerosis (MS) is a lifelong condition that impacts the brain ... that a common type of discomfort in MS is unusual ...
Lupus is an 'uncommon, complex, and poorly understood disease' and GPs may not recognise the early warning signs, according ...
The groundbreaking new NHS lupus therapy works by genetically modifying cells to enable the body's immune system to recognise ...
Three patients in the UK have received a “groundbreaking” treatment for lupus on the NHS, which experts hope could eradicate ...
The "Bowel Management Systems - Market Insights, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The bowel management systems market was valued at ...
Three patients in the UK have received a”groundbreaking” treatment for lupus on the NHS, which experts hope could eradicate ...
Until now, CAR T-cell therapy in the UK has been used only in cancer patients, but researchers believe it could treat range ...
Expansion of Phase 1 CALiPSO-1 trial of CNTY-101 in autoimmune disease to include diffuse cutaneous systemic sclerosis and idiopathic ...
Three patient receive ‘groundbreaking’ lupus treatment in the UK - Around 69,000 people in the UK are thought to have lupus, ...
Lupus can range from mild to severe, and leads to patients needing to take drugs for life, with common symptoms including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback